RxDoctor Payments Data

Cristina Rosales, PA

Physician Assistant · Montebello, CANPI 1215119821

Payments from drug & device makers

$4,240in general payments, 2019–2025

Across 210 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$803
  • Novo Nordisk$605
  • AbbVie$525
  • Amgen$373
  • Pfizer$287
  • Merck$196
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$4,240100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,240 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$18,857
Medicare patients
52
Services billed
379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin118$85,378
TrulicityDulaglutide70$65,858
EliquisApixaban40$35,010
OzempicSemaglutide27$30,927
TradjentaLinagliptin17$7,980
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$3,763
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp13$2,964
Humalog Kwikpen U-100Insulin Lispro12$2,647
Atorvastatin Calcium295$2,291
Duloxetine Hcl64$2,101
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$1,982
Levocetirizine Dihydrochloride29$1,343
Diclofenac Sodium ErDiclofenac Sodium27$1,308
Levothyroxine Sodium97$1,230
Metformin Hcl202$1,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$156$93,359135 claims
Lilly USA, LLCTrulicity$803$65,85870 claims
PfizerEliquis$287$35,01040 claims
Novo NordiskOzempic$605$30,92727 claims
AbbVieSynthroid$525$42713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Montebello

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →